Astonea Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TG901011
  • NSEID:
  • BSEID: 544409
INR
160.00
0.00 (0.00%)
BSENSE

Dec 16

BSE+NSE Vol: 105000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Astonea Labs Ltd stock-summary
stock-summary
Astonea Labs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Astonea Labs Limited was originally incorporated as "AHU Laboratories Private Limited", as a private limited company, pursuant to certificate of incorporation dated April 11, 2017. Company changed its name from AHU Laboratories Limited to "Astonea Labs Private Limited" dated February 26, 2019. Subsequently, the Company further changed the name to "Astonea Labs Limited", vide fresh Certificate of Incorporation dated January 11, 2024.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (2.51%)

Promoter with highest holding

Ashish Gulati (70.81%)

Highest Public shareholder

Swati Agarwala (1.47%)

Individual Investors Holdings

17.06%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases
9.8288
0%
 
100
Purchases
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 164 Cr (Micro Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.72

stock-summary
Return on Equity

10.01%

stock-summary
Price to Book

3.15